Abstract:559 Background: Early breast cancer (cT 1-2 N 0 ) with one or two sentinel lymph node (SLN) involved may avoid axillary lymph node dissection (ALND) if follow by radiotherapy supported by Z0011 and AMAROS trials. However, only less than one-third of those patients have positive non-sentinel lymph node (nSLN) and can truly benefit from radiotherapy or ALND in those two trials. It is necessary to identify the risk of nSLN metastasis before local treatment decision. We previously developed a predictive model for nSLN involvement using circulating CK19 mRNA level combined with contrast-enhanced ultrasound (CEUS) score (ASCO2017 poster 239, NCT02992067) in a training set. To evaluate the predict effect of this model, we designed a further study using the model prospectively in a validation set (NCT03280134). Methods: We identified early breast cancer cases in Zhejiang Cancer Hospital from July 2017 to June 2018. The level of circulating CK19 mRNA tested by qRT-PCR and CEUS scores were collected before surgery in each case. Patients with 1~2 SLN involved were enrolled and continued for ALND. The estimated percentage of nSLN-involved were calculated both by our model formula and the Memorial Sloan-Kettering Cancer Center (MSKCC) nomogram. The predictive accuracy and false negative rates (FNR) were evaluated and the area under curve (AUC) was compared between two predictive models. Results: Totally, 235 patients diagnosed as early breast cancer with 1~2 SLN involved were enrolled and 35.36% of them were nSLN involved after ALND. The total accuracy and FNR by our model for nSLN-involved prediction was 94.89% and 6.02%, respectively. The AUC was 0.952 (95%CI, 0.922~0.982), significantly higher than that in MSKCC model 0.880 (95%CI, 0.833~0.927). Furthermore, only CK19 mRNA level (HR = 40.091, 95%CI, 13.663~117.635) and CEUS score (HR = 2.009, 95%CI 1.158~3.485) are significantly related to nSLN involvement in both univariate and multivariate analysis, adjusted by age, menopause statue, tumor size, histological grade, estrogen receptor, progesterone receptor and human epidermalgrowth factor receptor-2 expression. Conclusions: Our model using CK19 mRNA and CEUS score showed potential predictive value of nSLN before surgery in early breast cancer patients. Further validation in larger multicenter cohort is warranted before changing clinical practice.

Prediction of Nonsentinel Lymph Node Metastasis in Acral Melanoma with Positive Sentinel Lymph Nodes.

High Risk For Non-Sentinel Node Metastasis In Breast Cancer Patients With Sentinel Node Metastases

The Prognostic Significance of Non‐sentinel Lymph Node Metastasis in Cutaneous and Acral Melanoma Patients—a Multicenter Retrospective Study

Role of Number of Sentinel Nodes in Predicting Non-Sentinel Node Metastasis in Breast Cancer

A Prospective Validation Cohort Study of a Prediction Model on Non-Sentinel Lymph Node Involvement in Early Breast Cancer.

Validation of the Memorial Sloan Kettering Cancer Center Nomogram for Predicting Non-Sentinel Lymph Node Metastasis in Sentinel Lymph Node-Positive Breast-Cancer Patients

Factors Predicting Non-Sentinel Lymph Node Status In Breast Cancer Patients With 1-2 Macrometastatic Positive Sentinel Lymph Nodes

A New Model for Predicting Nonsentinel Lymph Node Metastasis in Early-Stage Breast Cancer Using MMP15

Application of the Machine-Learning Model to Improve Prediction of Non-Sentinel Lymph Node Metastasis Status Among Breast Cancer Patients

Risk Factors and a Predictive Nomogram for Non-Sentinel Lymph Node Metastases in Chinese Breast Cancer Patients with One or Two Sentinel Lymph Node Macrometastases and Mastectomy.

A new model to predict risk of nonsentinel lymph node status in Chinese sentinel lymph node-positive patients after neoadjuvant chemotherapy.

Prognostic Value of the Number of Biopsied Sentinel Lymph Nodes for Chinese Patients with Melanoma: A Single-Center Retrospective Study

[A Nomogram to Predict Non-Sentinel Lymph Node Metastasis for Breast Cancer Patients with Positive Axillary Sentinel Lymph Node].

[Risk Factors of Non-Sentinel Lymph Node Metastasis and Performance of MSKCC Nomogramin Breast Cancer Patients with Metastatic Sentinel Lymph Node].

Survival impact of immediate complete lymph node dissection for Chinese acral and cutaneous melanoma with micrometastasis in sentinel nodes: a retrospective study

Complete lymph node dissection in cutaneous melanoma patients with positive sentinel lymph node: Outcome and predictors in a retrospective cohort study over 16 years

Validation and Comparison of Models to Predict Non-Sentinel Lymph Node Metastasis in Breast Cancer Patients.

NON-SENTINEL LYMPH NODE METASTASES IN CHINESE PATIENTS WITH BCa, Wang et al

Risk factors for non-sentinel lymph node metastasis in patients after neoadjuvant chemotherapy]

Development and validation of an ultrasonography and clinicopathological features-based nomogram for non-sentinel lymph node metastasis

Analysis of Factors Related to Non-Sentinel Lymph Node Metastasis in 296 Sentinel Lymph Node-Positive Chinese Breast Cancer Patients